Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Free Report) was the recipient of a significant decline in short interest during the month of February. As of February 29th, there was short interest totalling 35,000 shares, a decline of 64.3% from the February 14th total of 98,000 shares. Currently, 0.1% of the company’s stock are sold short. […]
LOS ALTOS, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company or
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Unicycive Therapeutics Announces Both An Oral And Poster Presentation To Be Delivered On UNI-494 At The Upcoming AKI And CRRT Conference menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.